Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials

SIMPLE SUMMARY: Patients with a metastatic rhabdomyosarcoma treated with a long-term maintenance therapy (LTMT) as a final additional treatment element show a similar outcome compared to a final high-dose chemotherapy regimen and a significantly better outcome compared to patients receiving an allog...

Descripción completa

Detalles Bibliográficos
Autores principales: Tramsen, Lars, Bochennek, Konrad, Sparber-Sauer, Monika, Salzmann-Manrique, Emilia, Scheer, Monika, Dantonello, Tobias, Borkhardt, Arndt, Dirksen, Uta, Thorwarth, Anne, Greiner, Jeanette, Ebinger, Martin, Weclawek-Tompol, Jadwiga, Ladenstein, Ruth, Ljungman, Gustaf, Hallmen, Erika, Lehrnbecher, Thomas, Koscielniak, Ewa, Klingebiel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093505/
https://www.ncbi.nlm.nih.gov/pubmed/37046711
http://dx.doi.org/10.3390/cancers15072050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093505/
https://www.ncbi.nlm.nih.gov/pubmed/37046711
http://dx.doi.org/10.3390/cancers15072050

Ejemplares similares